• Led R and D projects on Immunotherapy, Metabolism, and Process development in the field of engineered T-cell therapy• Represented the R and D team during customer-facing webinars, and conferences and published application notes.• Collaborated and developed project proposals and reports internally and with other divisions for R and D and marketing purposes.• Conceptualized and managed multi-disciplinary preclinical translational research team on glutaminase inhibitor that formed the basis of a clinical trial. • Recipient of a research grant to evaluate novel metabolic adaptive mechanisms in cervical cancer, established a cell line with unique metabolic features and drug sensitivity.